Roivant Sciences
Developing transformative medicines faster by building technologies and developing talent in creative ways. Learn more
Launch date
Employees
Market cap
€8.1b
Enterprise valuation
€3.3b (Public information from Sep 2024)
Share price
$11.97 ROIV
Company register number CHE-289.087.624
New York City New York (HQ), Basel Canton of Basel-Stadt (founding location)
No columns specified